- Home
- KYMR vs ESAB Comparison
KYMR vs ESAB Comparison
Compare KYMR & ESAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | KYMR | ESAB |
|---|---|---|
| Founded | 2015 | 1904 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Office Equipment/Supplies/Services |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.8B | 8.1B |
| IPO Year | 2020 | 2022 |
Fundamental Metrics
Financial Performance| Metric | KYMR | ESAB |
|---|---|---|
| Price | $81.65 | $108.16 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 26 | 8 |
| Target Price | $108.04 | ★ $144.13 |
| AVG Volume (30 Days) | ★ 710.3K | 357.8K |
| Earning Date | 01-01-0001 | 05-25-2026 |
| Dividend Yield | N/A | ★ 0.37% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ 3.67 |
| Revenue | $39,211,000.00 | ★ $2,842,555,000.00 |
| Revenue This Year | $16.05 | $6.42 |
| Revenue Next Year | $4.79 | $5.59 |
| P/E Ratio | ★ N/A | $29.43 |
| Revenue Growth | N/A | ★ 3.71 |
| 52 Week Low | $19.45 | $100.17 |
| 52 Week High | $103.00 | $137.42 |
Technical Indicators
Market Signals| Indicator | KYMR | ESAB |
|---|---|---|
| Relative Strength Index (RSI) | 47.15 | 29.84 |
| Support Level | $77.78 | N/A |
| Resistance Level | $95.90 | $118.33 |
| Average True Range (ATR) | 4.43 | 4.28 |
| MACD | -1.09 | -2.41 |
| Stochastic Oscillator | 14.60 | 12.61 |
Price Performance
Historical ComparisonAbout KYMR Kymera Therapeutics Inc.
Kymera Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to reinventing the treatment of human disease through the development of differentiated medicines that address health problems and meaningfully improve patients' lives. It is committed to novel technologies to address targets that have known disease-causing biology, but which have not been drugged, or have been inadequately drugged, often based on limitations of existing technologies. Its approach is intended to discover and develop a new generation of medicines in a disease-agnostic manner. Its product pipelines are STAT6, TYK2, and IRAK4.
About ESAB ESAB Corporation
ESAB, spun off from Colfax in 2022, is a leading manufacturer of equipment and consumables used in welding, cutting, and joining applications. Alongside competitors Lincoln Electric and ITW's Miller brand, ESAB is one of the top three players in the welding space. ESAB generated roughly $2.7 billion in revenue in 2024.